Category NEWS

Abcuro

Kardigan reported positive Phase 2 data for tonlamarsen in uncontrolled hypertension at ACC.26, published in JACC

Kardigan Announces Positive Phase 2 Data for Tonlamarsen in Patients with Uncontrolled Hypertension Presented as Late-Breaker at ACC.26 and Simultaneously Published in JACC Kardigan™, a clinical-stage precision therapeutics company developing medicines that target the root cause of specific cardiovascular diseases…

Read MoreKardigan reported positive Phase 2 data for tonlamarsen in uncontrolled hypertension at ACC.26, published in JACC
Anumana

Anumana received FDA clearance for a first-of-its-kind AI ECG tool to detect pulmonary hypertension early.

Anumana Secures FDA Clearance for First-of-Its-Kind ECG-AI Algorithm for Early Detection of Pulmonary Hypertension Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled software-as-a-medical-device (SaMD)…

Read MoreAnumana received FDA clearance for a first-of-its-kind AI ECG tool to detect pulmonary hypertension early.
Healthcare

Healthcare Digital wins 2026 AI Excellence Award for Nutrition AI with Morrison Healthcare.

Healthcare Digital Wins 2026 Artificial Intelligence Excellence Award for Nutrition AI, Developed in Collaboration with Morrison Healthcare Healthcare Digital, the healthcare and senior living division of Compass Digital and the technology arm for Compass Healthcare, today announced it has been named a winner…

Read MoreHealthcare Digital wins 2026 AI Excellence Award for Nutrition AI with Morrison Healthcare.
Abcuro

Abcuro shared Phase 2/3 MUSCLE study results for ulviprubart in inclusion body myositis at GCOM 2026.

Abcuro Presents Results from Phase 2/3 MUSCLE Study of Ulviprubart in Patients with Inclusion Body Myositis at GCOM 2026 Abcuro, Inc., a clinical stage biotechnology company, today presented results at the 6th Global Conference on Myositis (GCOM) meeting, being held March 23-26, 2026…

Read MoreAbcuro shared Phase 2/3 MUSCLE study results for ulviprubart in inclusion body myositis at GCOM 2026.
Major

Major Shortcomings Found in Diabetes Screening at Urgent Care Centers, Study Reveals

Massive Gaps Uncovered for Diabetes Screening in Urgent Care, Research Shows UCP Merchant Medicine, the leading provider of consulting services and clinical AI technology for Urgent Care, shared data collected with their Intellivisit software revealing significant gaps in diabetes screening…

Read MoreMajor Shortcomings Found in Diabetes Screening at Urgent Care Centers, Study Reveals

Roseman University Launches Roseman Bioventures, a 120,000-Square-Foot Life Science Incubator in Las Vegas

Roseman University Launches Roseman Bioventures, a 120,000-square-foot Life Science Incubator in Las Vegas Roseman University of Health Sciences today announced the launch of Roseman Bioventures in Las Vegas to accelerate the translation of scientific breakthroughs into therapies and technologies that…

Read MoreRoseman University Launches Roseman Bioventures, a 120,000-Square-Foot Life Science Incubator in Las Vegas
Arrowhead

Element Science Recognized on Fast Company’s 2026 List of the World’s Most Innovative Companies

Element Science Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 Element Science, a pioneering health technology company that has developed the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) to monitor and protect high-risk cardiovascular patients from sudden…

Read MoreElement Science Recognized on Fast Company’s 2026 List of the World’s Most Innovative Companies
Transcat

Houston’s Rice WaTER Institute Partners with Israel’s IDE Technologies to Advance Water Treatment Innovations

Houston’s Rice WaTER Institute and Israel’s IDE Technologies Collaborate to Advance Water Treatment Solutions IDE Technologies, a world leader in desalination and advanced water treatment solutions, and Rice University’s Water Technologies Entrepreneurship and Research (WaTER) Institute, a multidisciplinary center advancing…

Read MoreHouston’s Rice WaTER Institute Partners with Israel’s IDE Technologies to Advance Water Treatment Innovations
Arrowhead

Lineage initiates a new cell therapy program targeting corneal endothelial disease.

Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious medical conditions, today announced the expansion of its cell transplant pipeline…

Read MoreLineage initiates a new cell therapy program targeting corneal endothelial disease.
Novartis

Novartis to acquire Synnovation’s pan-mutant selective PI3Kα inhibitor program.

Novartis to Acquire Synnovation Therapeutics’ Pan-Mutant Selective PI3Kα Inhibitor Program Synnovation Therapeutics, LLC (“Synnovation”), a clinical-stage biotechnology company with a diverse pipeline of novel small-molecule targeted therapies in oncology and immunology today announced a definitive agreement for Novartis to acquire…

Read MoreNovartis to acquire Synnovation’s pan-mutant selective PI3Kα inhibitor program.